Article
Early detection of Alzheimer's disease using neuroimaging.
Experimental gerontology - 1 Jan 2000
Mosconi Lisa, Brys Miroslaw, Glodzik-Sobanska Lidia, De Santi Susan, Rusinek Henry, de Leon Mony J
Abstract excerpt
Neuroimaging is being increasingly used to complement clinical assessments in the early detection of Alzheimer's disease (AD). Structural magnetic resonance imaging (MRI) and metabolic positron emission tomography (FDG-PET) are the most clinically used and promising modalities to detect brain abnormalities in individuals who might be at risk for AD but who have not yet developed symptoms. The knowledge of...
Topics
- Alzheimer Disease
- Apolipoproteins E
- Brain
- Cognition Disorders
- Early Diagnosis
- Fluorodeoxyglucose F18
- Genotype
- Humans
- Image Processing, Computer-Assisted
- Magnetic Resonance Imaging
- Positron-Emission Tomography